JP2012217565A - Urination disorder treatment device - Google Patents

Urination disorder treatment device Download PDF

Info

Publication number
JP2012217565A
JP2012217565A JP2011085146A JP2011085146A JP2012217565A JP 2012217565 A JP2012217565 A JP 2012217565A JP 2011085146 A JP2011085146 A JP 2011085146A JP 2011085146 A JP2011085146 A JP 2011085146A JP 2012217565 A JP2012217565 A JP 2012217565A
Authority
JP
Japan
Prior art keywords
electrode
stimulation
ankle
point
urination disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011085146A
Other languages
Japanese (ja)
Inventor
Airi Takagi
愛理 高木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Corp
Original Assignee
Panasonic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panasonic Corp filed Critical Panasonic Corp
Priority to JP2011085146A priority Critical patent/JP2012217565A/en
Publication of JP2012217565A publication Critical patent/JP2012217565A/en
Withdrawn legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a noninvasive urination disorder treatment device allowing a patient oneself to easily have treatment.SOLUTION: This urination disorder treatment device includes: an stimulation application electrode 3 wherein an electrode face has a convex shape; a reference electrode 4 disposed on the skin surface of a desired portion of a human body; a wound part 6 including a hole part 11 in a portion disposed in an ankle 9 of the lower limb inner side face, winding the whole ankle 8 including an SP-6 point 10, and installed with the stimulation application electrode 3 in a position corresponding to the skin surface of the SP-6 point 10 decided with the hole part 11 as a reference; and a stimulation device 2 supplying a stimulation application signal having a voltage of prescribed magnitude decided to a potential of the reference electrode 4 to the stimulation application electrode 3.

Description

本発明は、特に失禁や頻尿を抑制する排尿障害治療装置に関するものである。   The present invention particularly relates to a dysuria treatment apparatus that suppresses incontinence and frequent urination.

失禁や頻尿といった排尿障害を、仙骨を通る神経を刺激して治療する方法がある。   There are methods of treating dysuria such as incontinence and frequent urination by stimulating nerves that pass through the sacrum.

図5の人体15側断面図で示すように、尿道括約筋16等の骨盤底筋群の動きを制御する陰部神経17と、膀胱18の動きを制御する骨盤内臓神経19とが仙骨20を通っている。そのため、仙骨20を介して、これら陰部神経17と骨盤内臓神経19とを刺激することで蓄排尿を制御することができる。   As shown in the sectional side view of the human body 15 in FIG. 5, the pudendal nerve 17 that controls the movement of the pelvic floor muscles such as the urethral sphincter 16 and the pelvic visceral nerve 19 that controls the movement of the bladder 18 pass through the sacrum 20. Yes. Therefore, accumulation and urination can be controlled by stimulating the pudendal nerve 17 and the pelvic visceral nerve 19 via the sacrum 20.

一方、後頚骨神経21は、足底から足首8の内側を通り、坐骨神経23を介して仙骨20に繋がっている。そのため、図6に示すような刺激装置24と針電極25、基準電極26およびリードケーブル27とで構成され、図7に示す下肢内側面28のくるぶし29から大よそ5〜6センチ膝方向部分に存在するSP−6ポイント30部分に針電極25を穿刺し、穿刺した針電極25へ刺激装置24から刺激印加信号を供給する排尿障害治療装置が提案されている(例えば、下記非特許文献1)。   On the other hand, the posterior tibial nerve 21 passes from the sole to the inside of the ankle 8 and is connected to the sacrum 20 via the sciatic nerve 23. Therefore, the stimulation device 24 as shown in FIG. 6, the needle electrode 25, the reference electrode 26, and the lead cable 27 is configured. From the ankle 29 on the inner side surface 28 of the lower limb shown in FIG. There has been proposed a urination disorder treatment apparatus that punctures an existing SP-6 point 30 portion with a needle electrode 25 and supplies a stimulation application signal from the stimulation device 24 to the punctured needle electrode 25 (for example, Non-Patent Document 1 below). .

SP−6ポイント30は、頸骨の直ぐ後ろの皮膚上にあり、後頸骨神経21に近接する皮膚上に位置する。SP−6ポイント30は経穴に相当し、山陰交とも呼ばれる。山陰交は、泌尿器疾患や消化器官を調節する経穴として知られている。   The SP-6 point 30 is on the skin immediately behind the tibia and is located on the skin close to the posterior tibial nerve 21. SP-6 point 30 corresponds to an acupuncture point and is also called San-in. San-in is known as an acupuncture point that regulates urological diseases and digestive organs.

Klingler HC、Pycha A、Schmidbauer J、Marberger M、「Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity:a urodynamic−based study.」、Urology、2000年11月1日、第56巻、第5号、766−771頁"Kingler HC, Pycha A, Schmidbauer J, Marberger M, Year of peri No., p. 766-771

しかしながら、前記従来の構成では、下肢のSP−6ポイントに針電極を穿刺するという侵襲性を有する治療であるから、患者にとって痛みや苦痛を伴うという課題を有していた。   However, since the conventional configuration is an invasive treatment in which a needle electrode is punctured at the SP-6 point of the lower limb, there is a problem that the patient is accompanied by pain and pain.

また、侵襲性を有する治療であることから、治療の都度、穿刺を医師等の医療従事者のもとで行う必要があり、簡便に治療することができないという課題を有していた。
そこで、本発明は、前記課題を解決するもので、針電極をSP−6ポイントに穿刺する必要がなく、患者自身が簡便に治療できる排尿障害治療装置を提供することを目的とする。
Further, since the treatment is invasive, it is necessary to perform puncture under a medical staff such as a doctor every time treatment is performed, and there is a problem that treatment cannot be performed easily.
SUMMARY OF THE INVENTION The present invention solves the above-described problems, and an object of the present invention is to provide a urination disorder treatment apparatus that can be easily treated by a patient without needing to puncture a needle electrode at an SP-6 point.

そして、この目的を達成するために本発明の排尿障害治療装置は、電極面が凸状の形状を有する刺激印加電極と、前記人体の所望の部位の皮膚表面上に配置される基準電極と、下肢内側面のくるぶしに配置する部分に穴部を備え、SP−6ポイントを含む足首全体を巻装し、前記穴部を基準として定められる前記SP−6ポイントの皮膚表面に対応する位
置に前記刺激印加電極を設置した巻装部と、前記基準電極の電位に対し定められる所定の大きさの電圧からなる前記刺激印加信号を前記刺激印加電極へ供給する刺激装置とを備えた構成とし、これにより所期の目的を達成することを特徴としたものである。
And in order to achieve this object, the urination disorder treatment device of the present invention comprises a stimulation applying electrode having a convex electrode surface, a reference electrode arranged on the skin surface of a desired part of the human body, A hole portion is provided in the ankle on the inner surface of the lower limb, the entire ankle including the SP-6 point is wound, and the SP-6 point defined on the basis of the hole portion is positioned at a position corresponding to the skin surface. A configuration comprising: a winding part in which a stimulation application electrode is installed; and a stimulation device that supplies the stimulation application signal having a voltage of a predetermined magnitude determined with respect to the potential of the reference electrode to the stimulation application electrode. It is characterized by achieving the intended purpose.

本発明の排尿障害治療装置によれば、電極面が凸状の形状を有する刺激印加電極と、前記人体の所望の部位の皮膚表面上に配置される基準電極と、下肢内側面のくるぶしに配置する部分に穴部を備え、SP−6ポイントを含む足首全体を巻装し、前記穴部を基準として定められる前記SP−6ポイントの皮膚表面に対応する位置に前記刺激印加電極を設置した巻装部と、前記基準電極の電位に対し定められる所定の大きさの電圧からなる前記刺激印加信号を前記刺激印加電極へ供給する刺激装置とを備えた構成としたものであり、針電極を患者のSP−6ポイントに穿刺する必要する必要もなく、非侵襲で治療を行うことができる。   According to the urination disorder treatment device of the present invention, the stimulation applying electrode whose electrode surface has a convex shape, the reference electrode disposed on the skin surface of the desired part of the human body, and the ankle on the inner side surface of the lower limb A winding portion provided with a hole portion in the portion to be wound, the entire ankle including the SP-6 point is wound, and the stimulation applying electrode is installed at a position corresponding to the skin surface of the SP-6 point determined with the hole portion as a reference And a stimulation device that supplies the stimulation application signal having a voltage of a predetermined magnitude determined with respect to the potential of the reference electrode to the stimulation application electrode. It is not necessary to puncture the SP-6 point, and treatment can be performed non-invasively.

その結果、患者への負担を軽減することが可能となり、また、穿刺に伴う穿刺部分への細菌等による感染の危険性も伴わないため安全に治療を実施することができる。さらに、治療の都度、医師等の医療従事者のもとで行う必要がなく、患者自身で簡便に治療を行うことができる。   As a result, it is possible to reduce the burden on the patient, and it is possible to safely perform treatment because there is no risk of infection due to bacteria or the like to the puncture part associated with puncture. Furthermore, it is not necessary to perform treatment under the medical staff such as a doctor for each treatment, and the treatment can be easily performed by the patient himself.

本発明の実施の形態1における排尿障害治療装置を示す図The figure which shows the dysuria treatment apparatus in Embodiment 1 of this invention 本発明の実施の形態1における排尿障害治療装置の巻装部を示す図The figure which shows the winding part of the urination disorder treatment apparatus in Embodiment 1 of this invention. 本発明の実施の形態2における排尿障害治療装置を示す図The figure which shows the dysuria treatment apparatus in Embodiment 2 of this invention 本発明の実施の形態2における排尿障害治療装置の巻装部を示す図The figure which shows the winding part of the urination disorder treatment apparatus in Embodiment 2 of this invention. 排尿障害を司る神経を示した人体側断面図Cross-sectional side view of the human body showing the nerve responsible for dysuria 従来の排尿障害治療装置を示す図The figure which shows the conventional urination disorder treatment apparatus SP−6ポイントの位置を示す下肢内側面図Lower limb inner side view showing the position of SP-6 point

以下に本発明の排尿障害治療装置の実施の形態を図面と共に説明する。   Embodiments of the urination disorder treatment apparatus of the present invention will be described below with reference to the drawings.

(実施の形態1)
図1は、本願発明の実施の形態1における排尿障害治療装置を示している。
(Embodiment 1)
FIG. 1 shows a urination disorder treatment apparatus according to Embodiment 1 of the present invention.

実施の形態1における排尿障害治療装置1は、刺激装置2、刺激印加電極3、基準電極4、リードケーブル5、巻装部6およびベルト部7から構成される。   The urination disorder treatment apparatus 1 according to the first embodiment includes a stimulation device 2, a stimulation application electrode 3, a reference electrode 4, a lead cable 5, a winding unit 6, and a belt unit 7.

刺激装置2は、リードケーブル5を介して刺激印加電極3と基準電極4とに電気的に接続されており、基準電極4の電位を基準として、刺激印加信号として矩形波のパルス信号を刺激印加電極3に供給するものである。   The stimulation device 2 is electrically connected to the stimulation application electrode 3 and the reference electrode 4 via a lead cable 5 and applies a rectangular pulse signal as a stimulation application signal with the potential of the reference electrode 4 as a reference. This is supplied to the electrode 3.

刺激印加電極3は、足首8の下肢内側面側のくるぶし9から大よそ5〜6センチ膝方向側のSP−6ポイント10の皮膚表面上に当接するものであって、刺激装置2からの刺激印加信号を、SP−6ポイント10を介して生体内部へ供給させるものである。そして、刺激印加電極3は、後述する巻装部6およびベルト部7で足首8を固定した際に確実に皮膚表面に当節するように電極面は凸状で形成されている。基準電極4は、所望の皮膚表面上に配置されるものであって、刺激装置2から刺激印加電極3に刺激印加信号を供給する際に、この基準電極4の電位を基準として刺激印加信号の大きさの電圧を定めるためのものである。   The stimulation application electrode 3 is abutted on the skin surface of the SP-6 point 10 on the knee direction side from the ankle 9 on the inner side of the lower limb of the ankle 8, and stimulates from the stimulation device 2. The applied signal is supplied into the living body via the SP-6 point 10. The stimulation applying electrode 3 has a convex electrode surface so that the ankle 8 is fixed to the skin surface when the ankle 8 is fixed by a winding part 6 and a belt part 7 which will be described later. The reference electrode 4 is arranged on a desired skin surface, and when supplying the stimulus application signal from the stimulator 2 to the stimulus application electrode 3, the potential of the stimulus application signal is based on the potential of the reference electrode 4. It is for determining the voltage of magnitude.

巻装部6の構成を図2に示す。巻装部6は、SP−6ポイント10を含む足首8全体を巻装するものであって、その材質は絶縁性を有する材質で構成される。下肢内側面のくるぶしに配置する部分にくるぶしが露出するように穴部11が設けられている。そして、この巻装部6には、足首8全体を巻装した後に、所望の締圧で固定することが可能なベルト部7が設けられている。すなわち、この巻装部6は、下肢内側面のくるぶしに穴部11を配置した後に足首8全体を巻装させ、その後にベルト部7によって巻装部6を足首8に確実に固定させる構成となっている。   The structure of the winding part 6 is shown in FIG. The winding part 6 winds the whole ankle 8 including the SP-6 point 10, and the material thereof is made of an insulating material. A hole 11 is provided so that the ankle is exposed at a portion disposed on the ankle on the inner side surface of the lower limb. The wound portion 6 is provided with a belt portion 7 that can be fixed with a desired tightening pressure after the entire ankle 8 is wound. That is, the winding part 6 is configured to wind the entire ankle 8 after placing the hole 11 in the ankle on the inner side surface of the lower limb, and then securely fix the winding part 6 to the ankle 8 by the belt part 7. It has become.

また、この巻装部6は、その内面に電極面が皮膚に当接するように刺激印加電極3が固定されている。この刺激印加電極3は、穴部11を基準としておおよそ5〜6センチ膝方向に固定されている。これは、SP−6ポイント10が足首8から5〜6センチ膝方向に存在するため、巻装部6を足首8全体に巻装した際、刺激印加電極3が、SP−6ポイント10に配置されるように対応したものである。   Further, the wound application part 6 has the stimulation applying electrode 3 fixed to the inner surface thereof so that the electrode surface comes into contact with the skin. The stimulation applying electrode 3 is fixed in a knee direction of about 5 to 6 cm with respect to the hole 11. This is because the SP-6 point 10 exists in the 5-6 cm knee direction from the ankle 8, so when the wound part 6 is wound around the entire ankle 8, the stimulation applying electrode 3 is arranged at the SP-6 point 10. It is a thing corresponding.

上記のような構成からなる巻装部6を足首8に装着することで、刺激印加電極3を確実にSP−6ポイント10の皮膚表面上に当接することができるので、巻装部6を足首8に装着後、刺激装置2から刺激印加電極を介してSP−6ポイント10へ刺激印加信号を供給することができる。そして、SP−6ポイント10に供給された刺激印加信号は、その信号が後頚骨神経に伝達し、仙骨にまで伝播するため、陰部神経および骨盤内臓神経を刺激して蓄排尿を制御して排尿障害を治療することができる。   By attaching the winding part 6 having the above-described configuration to the ankle 8, the stimulation applying electrode 3 can be surely brought into contact with the skin surface of the SP-6 point 10, so that the winding part 6 is attached to the ankle. After being attached to 8, the stimulation application signal can be supplied from the stimulation apparatus 2 to the SP-6 point 10 via the stimulation application electrode. Then, the stimulus application signal supplied to SP-6 point 10 is transmitted to the posterior tibial nerve and propagates to the sacrum, so that the pudendal nerve and pelvic visceral nerve are stimulated to control accumulation and urination. Can treat dysuria.

以上のように、本願発明の実施の形態1における排尿障害治療装置1を用いることで、巻装部6で足首8全体を固定した際に、凸状の刺激印加電極3が皮膚表面に確実に当接し、刺激印加信号を生体へ供給することができる。そして、巻装部6に設けられた穴部11を基準に巻装するだけで、刺激印加電極3を簡便且つ確実にSP−6ポイント位置に配置することができる。従って、非侵襲でかつ、簡便な装着で排尿障害治療を実施することが可能となる。   As described above, by using the urination disorder treatment device 1 according to the first embodiment of the present invention, when the entire ankle 8 is fixed by the wound portion 6, the convex stimulation application electrode 3 is reliably attached to the skin surface. The stimulus application signal can be supplied to the living body. Then, the stimulation applying electrode 3 can be simply and reliably placed at the SP-6 point position simply by winding with the hole 11 provided in the winding portion 6 as a reference. Therefore, it is possible to perform urination disorder treatment with non-invasive and simple wearing.

(実施の形態2)
図3は、本願発明の実施の形態2における排尿障害治療装置を示している。
(Embodiment 2)
FIG. 3 shows a urination disorder treatment apparatus according to Embodiment 2 of the present invention.

実施の形態1と異なる点は、図4に示すように巻装部6の内部に加圧空気を送って膨張させる袋状部材12を備えたことと、その袋状部材12に送気ケーブル14を介して加圧空気を供給する加圧空気供給装置13を備えた点が異なる。従って、実施の形態1と同様の構成については、説明を省略する。   The difference from the first embodiment is that a bag-like member 12 for inflating by sending pressurized air into the winding part 6 as shown in FIG. 4 is provided, and an air supply cable 14 is provided to the bag-like member 12. The point which provided the pressurized air supply apparatus 13 which supplies pressurized air via is different. Therefore, the description of the same configuration as that of Embodiment 1 is omitted.

実施の形態2における排尿障害治療装置1の巻装部6は、いわゆる血圧計のカフ部に類似する構成である。すなわち、下肢内側面のくるぶしに穴部11を配置した後に足首8全体を巻装させ、ベルト部7によって巻装部6を足首8に固定させた後、加圧空気供給装置13から送気ケーブル14を介して巻装部6の袋状部材12に向けて加圧空気を供給して使用される。   The winding part 6 of the urination disorder treatment apparatus 1 according to the second embodiment has a configuration similar to a cuff part of a so-called sphygmomanometer. That is, after placing the hole 11 in the ankle on the inner side surface of the lower limb, the entire ankle 8 is wound, the wound portion 6 is fixed to the ankle 8 by the belt portion 7, and then the air supply cable from the pressurized air supply device 13. The compressed air is supplied to the bag-like member 12 of the winding part 6 through 14 and used.

従って、実施の形態2の排尿障害治療装置1を用いることで、巻装部6による足首8全体および刺激印加電極4の固定を更に確実にすることができる。
また、凸状の刺激印加電極3を巻装部6の内側面に設けると、巻装部6に加圧空気が供給された時に凸状の刺激印加電極3とSP−6ポイント10部分の皮膚の密着性がより増加するため、皮膚と電極の接触抵抗が小さい状態で効果的な刺激ができる。
Therefore, by using the urination disorder treatment device 1 according to the second embodiment, the entire ankle 8 and the stimulation applying electrode 4 can be more reliably fixed by the wound portion 6.
Further, when the convex stimulation applying electrode 3 is provided on the inner surface of the wound part 6, the skin of the convex stimulation applying electrode 3 and the SP-6 point 10 when the pressurized air is supplied to the wound part 6. Therefore, effective stimulation can be performed in a state where the contact resistance between the skin and the electrode is small.

本発明の排尿障害治療装置光治療装置によれば、電極面が凸状の形状を有する刺激印加
電極と、前記人体の所望の部位の皮膚表面上に配置される基準電極と、下肢内側面のくるぶしに配置する部分に穴部を備え、SP−6ポイントを含む足首全体を巻装し、前記穴部を基準として定められる前記SP−6ポイントの皮膚表面に対応する位置に前記刺激印加電極を設置した巻装部と、前記基準電極の電位に対し定められる所定の大きさの電圧からなる前記刺激印加信号を前記刺激印加電極へ供給する刺激装置とを備えた構成としたものであるので、針電極を患者のSP−6ポイントに穿刺する必要する必要もなく、非侵襲で治療を行うことができる。
According to the phototherapy device of the urination disorder treatment device of the present invention, the stimulus application electrode having a convex shape on the electrode surface, the reference electrode disposed on the skin surface of the desired part of the human body, and the inner surface of the lower limb A hole portion is provided in an ankle portion, the entire ankle including the SP-6 point is wound, and the stimulation applying electrode is provided at a position corresponding to the skin surface of the SP-6 point defined with the hole portion as a reference. Since it has a configuration comprising an installed winding part and a stimulation device that supplies the stimulation application signal consisting of a voltage of a predetermined magnitude determined with respect to the potential of the reference electrode to the stimulation application electrode, The treatment can be performed non-invasively without the need to puncture the patient's SP-6 point.

その結果、患者への負担を軽減することが可能となり、また、穿刺に伴う穿刺部分への細菌等による感染の危険性も伴わないため安全に治療を実施することができる。
さらに、治療の都度、医師等の医療従事者のもとで行う必要がなく、患者自身で簡便に治療を行うことができる。
As a result, it is possible to reduce the burden on the patient, and it is possible to safely perform treatment because there is no risk of infection due to bacteria or the like to the puncture part associated with puncture.
Furthermore, it is not necessary to perform treatment under the medical staff such as a doctor for each treatment, and the treatment can be easily performed by the patient himself.

このため、家庭用で使用できる排尿障害治療装置として広く活用が期待される。   Therefore, it is expected to be widely used as a urination disorder treatment device that can be used at home.

1 排尿障害治療装置
2 刺激装置
3 刺激印加電極
4 基準電極
5 リードケーブル
6 巻装部
7 ベルト部
8 足首
9 くるぶし
10 SP−6ポイント
11 穴部
12 袋状部材
13 加圧空気供給装置
14 送気ケーブル
15 人体
16 尿道括約筋
17 陰部神経
18 膀胱
19 骨盤内臓神経
20 仙骨
21 後頚骨神経
22 足首
23 坐骨神経
24 刺激装置
25 針電極
26 基準電極
27 リードケーブル
28 下肢内側面
29 くるぶし
30 SP−6ポイント
DESCRIPTION OF SYMBOLS 1 Urination disorder treatment apparatus 2 Stimulation apparatus 3 Stimulation application electrode 4 Reference electrode 5 Lead cable 6 Winding part 7 Belt part 8 Ankle 9 Ankle 10 SP-6 point 11 Hole part 12 Bag-shaped member 13 Pressurized air supply apparatus 14 Air supply Cable 15 human body 16 urethral sphincter 17 pudendal nerve 18 urinary bladder 19 pelvic visceral nerve 20 sacrum 21 posterior tibial nerve 22 ankle 23 sciatic nerve 24 stimulator 25 needle electrode 26 reference electrode 27 lead cable 28 lower limb inner surface 29 ankle 30 SP-6 point

Claims (4)

電極面が凸状の形状を有する刺激印加電極と、
前記人体の所望の部位の皮膚表面上に配置される基準電極と、
下肢内側面のくるぶしに配置する部分に穴部を備え、SP−6ポイントを含む足首全体を巻装し、前記穴部を基準として定められる前記SP−6ポイントの皮膚表面に対応する位置に前記刺激印加電極を設置した巻装部と、
前記基準電極の電位に対し定められる所定の大きさの電圧からなる前記刺激印加信号を前記刺激印加電極へ供給する刺激装置とを備えたことを特徴とする排尿障害治療装置。
A stimulation applying electrode having a convex shape on the electrode surface;
A reference electrode disposed on the skin surface of a desired part of the human body;
A hole portion is provided in the ankle on the inner surface of the lower limb, the entire ankle including the SP-6 point is wound, and the SP-6 point defined on the basis of the hole portion is positioned at a position corresponding to the skin surface. A winding part provided with a stimulating electrode;
A urination disorder treatment apparatus comprising: a stimulation device that supplies the stimulation application signal having a voltage of a predetermined magnitude determined with respect to the potential of the reference electrode to the stimulation application electrode.
前記巻装部材は、前記足首を所望の締圧で固定するベルト部を備えたことを特徴とする排尿障害治療装置。   The urination disorder treatment apparatus, wherein the winding member includes a belt portion that fixes the ankle with a desired tightening pressure. 前記巻装部は、その内部に加圧空気を送って膨張させる袋状部材を備えたことを特徴とする排尿障害治療装置。   The wound portion includes a bag-like member that is inflated by sending pressurized air into the wound portion. 前記袋状部材に、加圧空気を送る加圧空気供給装置を備えたことを特徴とする排尿障害治療装置。   A urination disorder treatment apparatus comprising a pressurized air supply device for sending pressurized air to the bag-like member.
JP2011085146A 2011-04-07 2011-04-07 Urination disorder treatment device Withdrawn JP2012217565A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011085146A JP2012217565A (en) 2011-04-07 2011-04-07 Urination disorder treatment device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011085146A JP2012217565A (en) 2011-04-07 2011-04-07 Urination disorder treatment device

Publications (1)

Publication Number Publication Date
JP2012217565A true JP2012217565A (en) 2012-11-12

Family

ID=47269764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011085146A Withdrawn JP2012217565A (en) 2011-04-07 2011-04-07 Urination disorder treatment device

Country Status (1)

Country Link
JP (1) JP2012217565A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104906687A (en) * 2015-06-02 2015-09-16 孟祥慧 Electronic acupuncture therapeutic instrument
CN107949421A (en) * 2015-05-21 2018-04-20 多伦多大学管理委员会 System and method for treating urinary dysfunction
CN108778411A (en) * 2016-01-21 2018-11-09 卡拉健康公司 For treating the system for peripheral nerve modulation, method and apparatus with the relevant disease of overactive bladder
US11426579B2 (en) 2013-11-27 2022-08-30 Ebt Medical Inc. Systems, methods and kits for peripheral nerve stimulation
US11529513B2 (en) 2013-11-27 2022-12-20 Ebt Medical, Inc. Neuromodulation system
US11596785B2 (en) 2015-09-23 2023-03-07 Cala Health, Inc. Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors
US11633593B2 (en) 2013-11-27 2023-04-25 Ebt Medical, Inc. Treatment of pelvic floor disorders using targeted lower limb nerve stimulation
US11857778B2 (en) 2018-01-17 2024-01-02 Cala Health, Inc. Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
US11890468B1 (en) 2019-10-03 2024-02-06 Cala Health, Inc. Neurostimulation systems with event pattern detection and classification

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11426579B2 (en) 2013-11-27 2022-08-30 Ebt Medical Inc. Systems, methods and kits for peripheral nerve stimulation
US11633593B2 (en) 2013-11-27 2023-04-25 Ebt Medical, Inc. Treatment of pelvic floor disorders using targeted lower limb nerve stimulation
US11529513B2 (en) 2013-11-27 2022-12-20 Ebt Medical, Inc. Neuromodulation system
US11446489B2 (en) 2013-11-27 2022-09-20 Ebt Medical, Inc. Method for treating a patient having a pelvic floor dysfunction
CN107949421A (en) * 2015-05-21 2018-04-20 多伦多大学管理委员会 System and method for treating urinary dysfunction
JP2018521813A (en) * 2015-05-21 2018-08-09 ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント System and method for treatment of bladder dysfunction
CN107949421B (en) * 2015-05-21 2021-05-04 Ebt医药有限责任公司 System and method for treating urinary dysfunction
JP7231964B2 (en) 2015-05-21 2023-03-02 イービーティー メディカル,インコーポレイテッド Systems and methods for treating bladder dysfunction
JP7013023B2 (en) 2015-05-21 2022-01-31 イービーティー メディカル,インコーポレイテッド Systems and methods for the treatment of bladder dysfunction
JP2022046777A (en) * 2015-05-21 2022-03-23 イービーティー メディカル,インコーポレイテッド Systems and methods for treatment of urinary dysfunction
CN104906687A (en) * 2015-06-02 2015-09-16 孟祥慧 Electronic acupuncture therapeutic instrument
US11596785B2 (en) 2015-09-23 2023-03-07 Cala Health, Inc. Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors
CN108778411B (en) * 2016-01-21 2022-06-03 卡拉健康公司 Systems, methods, and devices for peripheral neuromodulation for treating diseases associated with overactive bladder
US11344722B2 (en) 2016-01-21 2022-05-31 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
JP2022001277A (en) * 2016-01-21 2022-01-06 カラ ヘルス, インコーポレイテッドCala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
JP2019510529A (en) * 2016-01-21 2019-04-18 カラ ヘルス, インコーポレイテッドCala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases associated with overactive bladder
CN108778411A (en) * 2016-01-21 2018-11-09 卡拉健康公司 For treating the system for peripheral nerve modulation, method and apparatus with the relevant disease of overactive bladder
US11918806B2 (en) 2016-01-21 2024-03-05 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation of the leg
US11857778B2 (en) 2018-01-17 2024-01-02 Cala Health, Inc. Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
US11890468B1 (en) 2019-10-03 2024-02-06 Cala Health, Inc. Neurostimulation systems with event pattern detection and classification

Similar Documents

Publication Publication Date Title
US11844943B2 (en) Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
JP2012217565A (en) Urination disorder treatment device
US9757584B2 (en) Methods and devices for performing electrical stimulation to treat various conditions
US9630004B2 (en) Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
AU2011305581B2 (en) Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US20220088373A1 (en) Methods and devices for performing electrical stimulation to treat various conditions
CN105431195B (en) System and method of the electro photoluminescence anal orifice and rectal intestine structure to treat anal function obstacle
US20180050216A9 (en) Methods and devices for treating migraines with electromagnetic stimulation
JP2016515869A (en) Method and apparatus for transcutaneous stimulation on palm and plantar surfaces
JP2018526142A (en) System and method for changing nerve conduction by transcutaneous direct current block
KR20160100900A (en) Implant unit delivery tool
RU2011129774A (en) TREATMENT
AU2019297205B2 (en) An ankle cuff for managing incontinence
US20210016087A1 (en) Occlusion therapy and pelvic stimulation system
JP2013500080A (en) Cooling system and method for conductive coils
Chen et al. Pressor effects on blood pressure induced by isovolumic bladder distension and electro-acupuncture stimulations in anesthetized rats

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131120

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20131212

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20140108

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20140306